MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, FBIO has $185,548K in assets. $123,365K in debts. $79,381K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
248.96%
Quick Ratio
229.61%
Cash Ratio
159.58%
Debt to Asset Ratio
66.49%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Equity investments, at fair valu...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Notes payable, long-term, net
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
79,381
Accounts receivable, net
29,783
Inventory
9,624
Other receivables
158
Prepaid expenses and other current assets
4,895
Assets held for sale
0
Total current assets
123,841
Property, plant and equipment, net
2,519
Operating lease right-of-use asset, net
12,302
Restricted cash
1,220
Equity investments, at fair value
17,660
Intangible assets, net
27,605
Other assets
401
Total assets
185,548
Accounts payable and accrued expenses
47,125
Income taxes payable
356
Common stock warrant liabilities
1
Operating lease liabilities, short-term
2,127
Partner company installment payments - licenses, short-term
0
Other current liabilities
135
Total current liabilities
49,744
Notes payable, long-term, net
52,417
Operating lease liabilities, long-term
12,672
Partner company redeemable perpetual preferred liability
7,085
Other long-term liabilities
1,447
Total liabilities
123,365
Cumulative redeemable perpetual preferred stock, 0.001 par value, 15,000,000 authorized, 5,000,000 designated series a shares, 3,427,138 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively, liquidation value of 25.00 per share
3
Common stock, 0.001 par value, 200,000,000 shares authorized, 31,364,094 and 27,908,839 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively
31
Additional paid-in-capital
783,891
Accumulated deficit
-734,052
Total stockholders' equity attributed to the company
49,873
Non-controlling interests
12,310
Total stockholders' equity (deficit)
62,183
Total liabilities and stockholders' equity (deficit)
185,548
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$79,381K Accounts receivable, net$29,783K Inventory$9,624K Prepaid expenses andother current assets$4,895K Other receivables$158K Total current assets$123,841K Intangible assets, net$27,605K Equity investments, atfair value$17,660K Operating leaseright-of-use asset, net$12,302K Property, plant andequipment, net$2,519K Restricted cash$1,220K Other assets$401K Total assets$185,548K Total liabilities andstockholders' equity...$185,548K Total liabilities$123,365K Total stockholders'equity (deficit)$62,183K Notes payable,long-term, net$52,417K Total currentliabilities$49,744K Operating leaseliabilities, long-term$12,672K Partner companyredeemable perpetual...$7,085K Other long-termliabilities$1,447K Total stockholders'equity attributed to...$49,873K Non-controlling interests$12,310K Accumulated deficit-$734,052K Accounts payable andaccrued expenses$47,125K Operating leaseliabilities, short-term$2,127K Income taxes payable$356K Other currentliabilities$135K Common stock warrantliabilities$1K Additionalpaid-in-capital$783,891K Common stock, 0.001 parvalue, 200,000,000...$31K Cumulative redeemableperpetual preferred...$3K

Fortress Biotech, Inc. (FBIO)

Fortress Biotech, Inc. (FBIO)